Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Beeson

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Selective DNAzyme-mediated cleavage of AChR mutant transcripts by targeting the mutation site or through mismatches in the binding armAmr Abdelgany, John Ealing, Matthew Wood, et al.
Current Opinion in Molecular Therapeutics|September 30, 2003
Ribozymes and siRNA for the treatment of diseases of the nervous systemMatthew J Wood, Barbara Trülzsch, Amr Abdelgany, et al.
Neurology|May 30, 2002
Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutationsRebecca Croxen, Angela Vincent, John Newsom-Davis, et al.
Muscle & Nerve|February 26, 2004
Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravisDomenico Marco Bonifati, Nick Willcox, Angela Vincent, et al.
Human Molecular Genetics|August 21, 2003
Therapeutic gene silencing in the nervous systemMatthew J A Wood, Barbara Trülzsch, Amr Abdelgany, et al.
Frontiers in Molecular Neuroscience|December 21, 2020
The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and HomeostasisPedro M Rodríguez Cruz, Judith Cossins, David Beeson, et al.
Journal of Neuromuscular Diseases|June 14, 2021
COVID-19 in a Cohort of Patients with Congenital Myasthenic SyndromeSetareh Alabaf, Karen O'Connell, Sithara Ramdas, et al.
Plos One|November 19, 2013
MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clustersInga Koneczny, Judith Cossins, Patrick Waters, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cellsAmr Abdelgany, M Khabir Uddin, Matthew Wood, et al.
Neuromuscular Disorders : NMD|December 4, 2013
Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interfaceRichard Webster, Wei-Wei Liu, Amina Chaouch, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Selective DNAzyme-mediated cleavage of AChR mutant transcripts by targeting the mutation site or through mismatches in the binding armAmr Abdelgany, John Ealing, Matthew Wood, et al.
Current Opinion in Molecular Therapeutics|September 30, 2003
Ribozymes and siRNA for the treatment of diseases of the nervous systemMatthew J Wood, Barbara Trülzsch, Amr Abdelgany, et al.
Neurology|May 30, 2002
Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutationsRebecca Croxen, Angela Vincent, John Newsom-Davis, et al.
Muscle & Nerve|February 26, 2004
Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravisDomenico Marco Bonifati, Nick Willcox, Angela Vincent, et al.
Human Molecular Genetics|August 21, 2003
Therapeutic gene silencing in the nervous systemMatthew J A Wood, Barbara Trülzsch, Amr Abdelgany, et al.
Frontiers in Molecular Neuroscience|December 21, 2020
The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and HomeostasisPedro M Rodríguez Cruz, Judith Cossins, David Beeson, et al.
Journal of Neuromuscular Diseases|June 14, 2021
COVID-19 in a Cohort of Patients with Congenital Myasthenic SyndromeSetareh Alabaf, Karen O'Connell, Sithara Ramdas, et al.
Plos One|November 19, 2013
MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clustersInga Koneczny, Judith Cossins, Patrick Waters, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Design of efficient DNAzymes against muscle AChR alpha-subunit cRNA in vitro and in HEK 293 cellsAmr Abdelgany, M Khabir Uddin, Matthew Wood, et al.
Neuromuscular Disorders : NMD|December 4, 2013
Fast-channel congenital myasthenic syndrome with a novel acetylcholine receptor mutation at the α-ε subunit interfaceRichard Webster, Wei-Wei Liu, Amina Chaouch, et al.
Pageof 14